Y
Yoshikazu Inoue
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 273
Citations - 17662
Yoshikazu Inoue is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 48, co-authored 233 publications receiving 12648 citations. Previous affiliations of Yoshikazu Inoue include Niigata University.
Papers
More filters
Journal ArticleDOI
Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases.
Nishant Gupta,Riffat Meraj,Daniel M. Tanase,Laura E. James,Kuniaki Seyama,David A. Lynch,Masanori Akira,Cristopher A. Meyer,Stephen J. Ruoss,Charles D. Burger,Lisa R. Young,Khalid F. Almoosa,Srihari Veeraraghavan,Alan F. Barker,Augustine S. Lee,Daniel F. Dilling,Yoshikazu Inoue,Corey J. Cudzilo,Muhammad A. Zafar,Francis X. McCormack +19 more
TL;DR: Bronchiectasis and bullous changes seen in chronic obstructive pulmonary disease can also produce high-resolution computed tomography (HRCT) patterns that mimic the DCLDs.
Journal ArticleDOI
Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice.
Masaji Okada,Yoko Kita,Noriko Kanamaru,Satomi Hashimoto,Yasushi Uchiyama,Masahiko Mihara,Yoshikazu Inoue,Yoshiyuki Ohsugi,Tadamitsu Kishimoto,Mitsunori Sakatani +9 more
TL;DR: IL-6R blockade promotes the progression of TB infection in mice far less than TNF-α blockade, and results in anti-IL- 6R Ab-treated mice suggest that spleen cell responses were decreased to a lesser degree.
Journal ArticleDOI
Enhanced mast cell chymase expression in human idiopathic interstitial pneumonia.
Kazuto Hirata,Yoshimi Sugama,Yoshihiro Ikura,Masahiko Ohsawa,Yoshikazu Inoue,Satoru Yamamoto,M Kitaichi,Makiko Ueda +7 more
TL;DR: Observations suggest that mast cell chymase, possibly induced by interleukin-4-dependent phenotypic modulation, may be an important mediator in the inflammatory and fibrotic processes of idiopathic interstitial pneumonia in humans.
Journal ArticleDOI
Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study
Noriyuki Enomoto,Ryoko Egashira,Kazuhiro Tabata,Mikiko Hashisako,Mikiko Hashisako,Masashi Kitani,Yuko Waseda,Tamotsu Ishizuka,Satoshi Watanabe,Kazuo Kasahara,Shinyu Izumi,Akira Shiraki,Atsushi Miyamoto,Kazuma Kishi,Tomoo Kishaba,Chikatosi Sugimoto,Yoshikazu Inoue,Kensuke Kataoka,Yasuhiro Kondoh,Yutaka Tsuchiya,Tomohisa Baba,Hiroaki Sugiura,Tomonori Tanaka,Hiromitsu Sumikawa,Takafumi Suda +24 more
TL;DR: Chronic IP was the most frequent form of IP in patients with SLE-IP, and “Unclassifiable” was the commonest pattern radiologically and histologically, in this multicentre study.
Journal ArticleDOI
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis: Results of two 52-week, Phase III, randomized, placebo-controlled trials (INPULSIS™)
Ulrich Costabel,L Richeldi,R M du Bois,Ganesh Raghu,Arata Azuma,Kevin K. Brown,Vincent Cottin,Kevin R. Flaherty,Yoshikazu Inoue,Dong Soon Kim,Martin Kolb,Paul W. Noble,Moisés Selman,Hiroyuki Taniguchi,Michèle Brun,Mannaig Girard,Rozsa Schlenker-Herceg,Bernd Disse,Harold R. Collard +18 more